| Literature DB >> 19591829 |
Hoe-Suk Kim1, Sang Yoon Park, Yu Rim Choi, Jeong Gu Kang, Hyun Jung Joo, Woo Kyung Moon, Jin Won Cho.
Abstract
Increased modification of proteins with O-linked N-acetylglucosamine (O-GlcNAc) has been implicated in the development of diabetic cardiomyopathy. We used the well-characterized ES cells (Nkx2.5GFP knock-in ES cells), to investigate the role of O-GlcNAcylation in cardiomyocyte development. O-GlcNAcylation decreased in differentiating ES cells, as did the expression of O-GlcNAc transferase. Increasing O-GlcNAcylation with glucosamine or by inhibiting N-acetylglucosaminidase (streptozotocin or PUGNAc) decreased the number of cardiomyocyte precursors and cardiac-specific gene expression. On the other hand, decreasing O-GlcNAcylation with an inhibitor of glutamine fructose-6-phosphate amidotransferase (6-diazo-5-oxo-norleucine) increased cardiomyocyte precursors. These results suggest that excessive O-GlcNAcylation impairs cardiac cell differentiation in ES cells.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19591829 DOI: 10.1016/j.febslet.2009.06.052
Source DB: PubMed Journal: FEBS Lett ISSN: 0014-5793 Impact factor: 4.124